- Voyager Therapeutics, Inc (NASDAQ: VYGR) CEO and President Andre Turenne will step down as the beleaguered company announced it would move focus to early, discovery-stage efforts.
- The company’s CMO and R&D chief, Omar Khwaja, also stepped down after two years at the biotech.
- Voyager said that Turenne would leave to “pursue other opportunities,” and Khwaja found a new opportunity in Europe.
- Accordingly, the company …
Full story available on Benzinga.com